Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

Pertrochanteric Hip Fracture Clinical Trial

Official title:

Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02285127
• Other study ID #: 14-002490
• Status: Completed
• Phase: N/A
• Start date: November 2014
• Est. completion date: September 2019

Study information

• Verified date: May 2023
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Is there a functional outcome difference when treating pertrochanteric fractures with a short or long cephalomedullary nail?

Recruitment information / eligibility

• Status: Completed
• Enrollment: 168
• Est. completion date: September 2019
• Est. primary completion date: May 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria

• AO/OTA fracture classification 31(A-B) (1-3).

• Age greater than 18 years old.

Exclusion Criteria

-Less than 18 years old.

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fractures
• Pertrochanteric Hip Fracture

Intervention

Procedure:
• Short versus long cephalomedullary Intramedullary nail
Biomet Affixus Short and Long hip fracture nail. Stryker Gamma Short and Long hip fracture nail.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Reoperation		within 1 year
Other	Mortality		1 year
Primary	SF (short form)-36		3 months
Secondary	Harris Hip Score		3 months

External Links

•   Mayo Clinic Clinical Trials